Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
STOCK MARKET

RIL, Landmark Cars, Ajanta Pharma, Lupin in Spotlight

Picture Source: Internet

Reliance Strategic Business Ventures (RSBVL), a wholly owned subsidiary of Reliance Industries Ltd, has acquired a 23.3% stake in Exyn Technologies Inc (Exyn) for $25 million.

Abans Holdings’ shares will debut on the bourses on December 23, 2022. The issue price is Rs 270 per share.

Today, Landmark Cars’ shares will be listed on the bourses, and the issue price is Rs 506 per share.

Godrej Properties has announced the agreement to develop 14.27 acres of land in Haryana. The development will comprise predominantly premium residential apartments.

Ajanta Pharma informed that promoter(s) sold 4.38% of shares yesterday. The company proposes to utilise these funds for financing their respective private businesses, including repayment of loans taken against the pledge of shares of the company.

Lupin Pharmaceuticals Inc voluntarily recalled four lots of Quinapril Tablets to the patient level due to an N-Nitroso-Quinapril, nitrosamine impurity observed in recent testing above the Acceptable Daily Intake (ADI) level. The report has been received by Lupin of illness that appears to relate to this issue. In September, Lupin discontinued the marketing of Quinapril tablets.

Rail Vikas Nigam (RVNL) has been awarded a contract for the ‘Construction of Bhesan Depot cum Workshop including BCC, DDC, DC 2’ by Gujarat Metro Rail Corporation (GMRC) and associated E&M works for Surat Metro Rail Project Phase-1. The total cost of the award is Rs 198.93 crore.

Get Daily Prediction & Stocks Tips On Your Mobile